
Sean E. Aeder
Examiner (ID: 2139, Phone: (571)272-8787 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642 |
| Total Applications | 1939 |
| Issued Applications | 907 |
| Pending Applications | 201 |
| Abandoned Applications | 855 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5747467
[patent_doc_number] => 20060110398
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-25
[patent_title] => 'DAP-10 and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/284685
[patent_app_country] => US
[patent_app_date] => 2005-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 17040
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20060110398.pdf
[firstpage_image] =>[orig_patent_app_number] => 11284685
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/284685 | DAP-10 and uses thereof | Nov 21, 2005 | Abandoned |
Array
(
[id] => 4852069
[patent_doc_number] => 20080317811
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-25
[patent_title] => 'Treatment of Cancer Using Tlr3 Agonists'
[patent_app_type] => utility
[patent_app_number] => 11/718316
[patent_app_country] => US
[patent_app_date] => 2005-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 27502
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20080317811.pdf
[firstpage_image] =>[orig_patent_app_number] => 11718316
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/718316 | Treatment of Cancer Using Tlr3 Agonists | Nov 17, 2005 | Abandoned |
Array
(
[id] => 5850567
[patent_doc_number] => 20060233758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-19
[patent_title] => 'Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers'
[patent_app_type] => utility
[patent_app_number] => 11/274885
[patent_app_country] => US
[patent_app_date] => 2005-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13999
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20060233758.pdf
[firstpage_image] =>[orig_patent_app_number] => 11274885
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/274885 | Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers | Nov 15, 2005 | Abandoned |
Array
(
[id] => 5040635
[patent_doc_number] => 20070092917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-26
[patent_title] => 'Biomarkers for screening, predicting, and monitoring prostate disease'
[patent_app_type] => utility
[patent_app_number] => 11/274931
[patent_app_country] => US
[patent_app_date] => 2005-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 119
[patent_figures_cnt] => 119
[patent_no_of_words] => 31108
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11274931
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/274931 | Biomarkers for screening, predicting, and monitoring prostate disease | Nov 13, 2005 | Abandoned |
Array
(
[id] => 7591161
[patent_doc_number] => 07662924
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-16
[patent_title] => 'Beta chain-associated regulator of apoptosis'
[patent_app_type] => utility
[patent_app_number] => 11/267986
[patent_app_country] => US
[patent_app_date] => 2005-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 36234
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/662/07662924.pdf
[firstpage_image] =>[orig_patent_app_number] => 11267986
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/267986 | Beta chain-associated regulator of apoptosis | Nov 6, 2005 | Issued |
Array
(
[id] => 5874055
[patent_doc_number] => 20060166231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-27
[patent_title] => 'Molecular indicators of breast cancer prognosis and prediction of treatment response'
[patent_app_type] => utility
[patent_app_number] => 11/267807
[patent_app_country] => US
[patent_app_date] => 2005-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13977
[patent_no_of_claims] => 75
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20060166231.pdf
[firstpage_image] =>[orig_patent_app_number] => 11267807
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/267807 | Molecular indicators of breast cancer prognosis and prediction of treatment response | Nov 3, 2005 | Issued |
Array
(
[id] => 5828078
[patent_doc_number] => 20060063213
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-23
[patent_title] => 'Method of cancer screening; method of cancer treatment; and method of diabetes treatment'
[patent_app_type] => utility
[patent_app_number] => 11/261849
[patent_app_country] => US
[patent_app_date] => 2005-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2462
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20060063213.pdf
[firstpage_image] =>[orig_patent_app_number] => 11261849
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/261849 | Method of cancer screening; method of cancer treatment; and method of diabetes treatment | Oct 26, 2005 | Abandoned |
Array
(
[id] => 5826862
[patent_doc_number] => 20060062759
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-23
[patent_title] => 'Method of cancer screening; method of cancer treatment; and method of diabetes treatment'
[patent_app_type] => utility
[patent_app_number] => 11/261850
[patent_app_country] => US
[patent_app_date] => 2005-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2462
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20060062759.pdf
[firstpage_image] =>[orig_patent_app_number] => 11261850
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/261850 | Method of cancer screening; method of cancer treatment; and method of diabetes treatment | Oct 26, 2005 | Abandoned |
Array
(
[id] => 5812958
[patent_doc_number] => 20060083683
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-20
[patent_title] => 'Antibody fragment-polymer conjugates and uses of same'
[patent_app_type] => utility
[patent_app_number] => 11/259232
[patent_app_country] => US
[patent_app_date] => 2005-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 144
[patent_figures_cnt] => 144
[patent_no_of_words] => 111545
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0083/20060083683.pdf
[firstpage_image] =>[orig_patent_app_number] => 11259232
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/259232 | Antibody fragment-polymer conjugates and uses of same | Oct 24, 2005 | Issued |
Array
(
[id] => 5337897
[patent_doc_number] => 20090054361
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-26
[patent_title] => 'Pot1 alternative splicing variants'
[patent_app_type] => utility
[patent_app_number] => 11/665944
[patent_app_country] => US
[patent_app_date] => 2005-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 17644
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20090054361.pdf
[firstpage_image] =>[orig_patent_app_number] => 11665944
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/665944 | Pot1 alternative splicing variants | Oct 18, 2005 | Issued |
Array
(
[id] => 5246981
[patent_doc_number] => 20070243215
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-18
[patent_title] => 'Adjuvant for Dna Vaccines'
[patent_app_type] => utility
[patent_app_number] => 11/576312
[patent_app_country] => US
[patent_app_date] => 2005-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8909
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0243/20070243215.pdf
[firstpage_image] =>[orig_patent_app_number] => 11576312
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/576312 | Adjuvant for Dna Vaccines | Oct 6, 2005 | Abandoned |
Array
(
[id] => 5800208
[patent_doc_number] => 20060035292
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-16
[patent_title] => 'Differential diagnosis of cancer and other conditions based on expression of p63'
[patent_app_type] => utility
[patent_app_number] => 11/236310
[patent_app_country] => US
[patent_app_date] => 2005-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9190
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20060035292.pdf
[firstpage_image] =>[orig_patent_app_number] => 11236310
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/236310 | Differential diagnosis of cancer and other conditions based on expression of p63 | Sep 25, 2005 | Abandoned |
Array
(
[id] => 4711024
[patent_doc_number] => 20080299550
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-04
[patent_title] => 'Methods and Kits For the Prediction of Therapeutic Success and Recurrence Free Survival In Cancer Therapy'
[patent_app_type] => utility
[patent_app_number] => 11/664380
[patent_app_country] => US
[patent_app_date] => 2005-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 25639
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0299/20080299550.pdf
[firstpage_image] =>[orig_patent_app_number] => 11664380
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/664380 | Methods and Kits For the Prediction of Therapeutic Success and Recurrence Free Survival In Cancer Therapy | Sep 21, 2005 | Abandoned |
Array
(
[id] => 5271001
[patent_doc_number] => 20090074777
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'WNT PROTEINS AND DETECTION AND TREATMENT OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 11/909308
[patent_app_country] => US
[patent_app_date] => 2005-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 27382
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20090074777.pdf
[firstpage_image] =>[orig_patent_app_number] => 11909308
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/909308 | Wnt proteins and detection and treatment of cancer | Sep 20, 2005 | Issued |
Array
(
[id] => 7515147
[patent_doc_number] => 08039218
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-10-18
[patent_title] => 'Detection of cancer cells in body fluids'
[patent_app_type] => utility
[patent_app_number] => 11/227575
[patent_app_country] => US
[patent_app_date] => 2005-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 14721
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 210
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/039/08039218.pdf
[firstpage_image] =>[orig_patent_app_number] => 11227575
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/227575 | Detection of cancer cells in body fluids | Sep 13, 2005 | Issued |
Array
(
[id] => 334136
[patent_doc_number] => 07507547
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-03-24
[patent_title] => 'Screening assays for antioxidants and antiproliferative compounds'
[patent_app_type] => utility
[patent_app_number] => 11/223395
[patent_app_country] => US
[patent_app_date] => 2005-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 45
[patent_no_of_words] => 21252
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/507/07507547.pdf
[firstpage_image] =>[orig_patent_app_number] => 11223395
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/223395 | Screening assays for antioxidants and antiproliferative compounds | Sep 8, 2005 | Issued |
Array
(
[id] => 5726863
[patent_doc_number] => 20060057623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-16
[patent_title] => 'SENP1 as a marker of cancer development and target for cancer therapy'
[patent_app_type] => utility
[patent_app_number] => 11/214440
[patent_app_country] => US
[patent_app_date] => 2005-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 39395
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0057/20060057623.pdf
[firstpage_image] =>[orig_patent_app_number] => 11214440
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/214440 | SENP1 as a marker of cancer development and target for cancer therapy | Aug 28, 2005 | Issued |
Array
(
[id] => 112107
[patent_doc_number] => 07713693
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2010-05-11
[patent_title] => 'Human cancer cell specific gene transcript'
[patent_app_type] => utility
[patent_app_number] => 11/207697
[patent_app_country] => US
[patent_app_date] => 2005-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 24
[patent_no_of_words] => 5910
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/713/07713693.pdf
[firstpage_image] =>[orig_patent_app_number] => 11207697
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/207697 | Human cancer cell specific gene transcript | Aug 21, 2005 | Issued |
Array
(
[id] => 5748356
[patent_doc_number] => 20060111288
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-25
[patent_title] => 'Peripheral benzodiazepine receptor independent superoxide generation'
[patent_app_type] => utility
[patent_app_number] => 11/204795
[patent_app_country] => US
[patent_app_date] => 2005-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6277
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20060111288.pdf
[firstpage_image] =>[orig_patent_app_number] => 11204795
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/204795 | Peripheral benzodiazepine receptor independent superoxide generation | Aug 15, 2005 | Abandoned |
Array
(
[id] => 5726351
[patent_doc_number] => 20060057111
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-16
[patent_title] => 'Treatment of hyperproliferative disease with superantigens in combination with another anticancer agent'
[patent_app_type] => utility
[patent_app_number] => 11/202507
[patent_app_country] => US
[patent_app_date] => 2005-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 46896
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0057/20060057111.pdf
[firstpage_image] =>[orig_patent_app_number] => 11202507
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/202507 | Treatment of hyperproliferative disease with superantigens in combination with another anticancer agent | Aug 11, 2005 | Issued |